316 research outputs found
Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man
The current test systems employed by pharmaceutical industry are poorly predictive for drug-induced liver injury (DILI). The ‘MIP-DILI’ project addresses this situation by the development of innovative preclinical test systems which are both mechanism-based and of physiological, pharmacological and pathological relevance to DILI in humans. An iterative, tiered approach with respect to test compounds, test systems, bioanalysis and systems analysis is adopted to evaluate existing models and develop new models that can provide validated test systems with respect to the prediction of specific forms of DILI and further elucidation of mechanisms. An essential component of this effort is the choice of compound training set that will be used to inform refinement and/or development of new model systems that allow prediction based on knowledge of mechanisms, in a tiered fashion. In this review, we focus on the selection of MIP-DILI training compounds for mechanism-based evaluation of non-clinical prediction of DILI. The selected compounds address both hepatocellular and cholestatic DILI patterns in man, covering a broad range of pharmacologies and chemistries, and taking into account available data on potential DILI mechanisms (e.g. mitochondrial injury, reactive metabolites, biliary transport inhibition, and immune responses). Known mechanisms by which these compounds are believed to cause liver injury have been described, where many if not all drugs in this review appear to exhibit multiple toxicological mechanisms. Thus, the training compounds selection offered a valuable tool to profile DILI mechanisms and to interrogate existing and novel in vitro systems for the prediction of human DILI
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research
(Table 6) Age and depth determination of planktonic foraminifer datums in Kane Gap ODP holes
Synchroneity of Pliocene planktonic foraminiferal datums in the North Atlantic
Leg 94 of the Deep Sea Drilling Project has provided a unique set of paleomagnetically dated cores, taken along a N-S transect in the North Atlantic. High deposition rates in the sediments, combined with the palaeomagnetic ages, have enabled existing planktonic foraminiferal zonations to be tested and a new zonation for the mid- to high latitudes to be erected. The PL zonation of Berggren (1973, 1977) is shown to be adequate as far north as 41°N, although both the LAD's of Globigerina nepenthes and Globorotalia margaritae occur earlier than in tropical regions. North of 41°N these two species have very diachronous LAD's, even though they are common during their range in the northern sites. The new zonation for the mid to high latitude North Atlantic is based on the FAD of G. margaritae, FAD of G. puncticulata, LAD of G. cf. crassula, LAD of N. atlantica, FAD of G. inflata and FAD of sinistrally coiled encrusted N. pachyderma
(Table 1) Ages of planktonic foraminiferal datums at Leg 94 Sites
The six Leg 94 sites have produced a unique data set from a north-south transect of sites, all with good paleomagnetic records, and all but one with above-average accumulation rates. We show that it is necessary to have high accumulation rates to obtain good quality magnetobiostratigraphies, and that it is difficult to correlate geological sequences over distances of several hundred kilometers without independent age control. Using the paleomagnetically derived ages for species ranges, we show several examples of diachronic first and last appearance datums between the core sites. This has enabled us to test the existing zonal schemes for the Pliocene-Pleistocene and to identify new zonal markers
- …